Hofmann Amun Georg, Leinweber Maria Elisabeth, Assadian Afshin, Falkensammer Juergen, Taher Fadi
Department of Vascular and Endovascular Surgery, Klinik Ottakring, Montleartstrasse 37, Pavillon 30B, 1160 Vienna, Austria.
Department of Vascular Surgery, Barmherzige Brueder Hospital, 4020 Linz, Austria.
J Clin Med. 2023 Jun 5;12(11):3858. doi: 10.3390/jcm12113858.
Fenestrated endovascular aortic repair (FEVAR) has become a popular custom-made treatment option for juxtarenal and pararenal aneurysms. It has been previously investigated whether octogenarians as a distinct subgroup are at increased risk for adverse outcomes after FEVAR. With diverging results and an inconclusive understanding of age as a risk factor in general, an analysis of the historical data of a single center was conducted to add to the available body of evidence and further investigate the effect of age as a continuous risk factor.
A retrospective data analysis of a prospectively maintained single-center database of all patients who underwent FEVAR at a single department of vascular surgery was performed. The main endpoint was post-operative survival. In addition to association analyses, potential confounders such as co-morbidities, complication rates, or aneurysm diameter were examined. In terms of sensitivity analyses, logistic regression models were created for the dependent variables of interest.
During the observation period from April 2013 to November 2020, 40 patients over the age of 80 and 191 patients under the age of 80 were treated by FEVAR. The 30-day survival showed no significant difference between the groups (95.1% in octogenarians and 94.3% in patients under 80 years of age). The sensitivity analyses conducted also showed no difference between the two groups, and complication and technical success rates were comparable. The aneurysm diameter was 67 ± 13 mm in the study group and 61 ± 15 mm in those under 80 years of age. Additionally, the sensitivity analyses showed that age as a continuous variable exhibits no effect on the outcomes of interest.
In the present study, age was not associated with adverse peri-operative outcomes after FEVAR, including mortality, lower technical success rates, complications, or length of hospital stay. Essentially, the most highly associated factor with hospital and ICU length of stay was time spent in surgery. However, octogenarians had a significantly larger aortic diameter at the time of treatment, which might indicate the potential introduction of bias by pre-interventional patient selection. Nevertheless, the usefulness of research on octogenarians as a distinct subgroup might be questionable regarding the scalability of results, and future studies might focus on age as a continuous risk factor instead.
开窗式血管内主动脉修复术(FEVAR)已成为治疗近肾动脉和肾旁动脉瘤的一种流行的定制治疗选择。此前已有研究探讨了80岁及以上这一特定亚组患者在接受FEVAR治疗后出现不良结局的风险是否增加。由于结果存在分歧,且总体上对年龄作为风险因素的认识尚无定论,因此对单一中心的历史数据进行了分析,以补充现有证据,并进一步研究年龄作为连续风险因素的影响。
对前瞻性维护的单一血管外科科室所有接受FEVAR治疗患者的单中心数据库进行回顾性数据分析。主要终点是术后生存率。除了进行关联分析外,还检查了潜在的混杂因素,如合并症、并发症发生率或动脉瘤直径。在敏感性分析方面,针对感兴趣的因变量创建了逻辑回归模型。
在2013年4月至2020年11月的观察期内,40例80岁以上患者和191例80岁以下患者接受了FEVAR治疗。两组的30天生存率无显著差异(80岁及以上患者为95.1%,80岁以下患者为94.3%)。进行的敏感性分析也显示两组之间无差异,并发症和技术成功率相当。研究组的动脉瘤直径为67±13mm,80岁以下患者为61±15mm。此外,敏感性分析表明,年龄作为连续变量对感兴趣的结局没有影响。
在本研究中,年龄与FEVAR术后的围手术期不良结局无关,包括死亡率、较低的技术成功率、并发症或住院时间。从本质上讲,与住院和重症监护病房住院时间最密切相关的因素是手术时间。然而,80岁及以上患者在治疗时的主动脉直径明显更大,这可能表明干预前患者选择存在潜在偏差。尽管如此,将80岁及以上患者作为一个独特亚组进行研究的实用性在结果的可扩展性方面可能存在疑问,未来的研究可能会将重点放在年龄作为连续风险因素上。